Tanke Biosciences Corp (OTC:TNBI) Stock Soars: Here is Why

In light of the announcement made by Tanke Biosciences Corp. (OTC:TNBI) on Tuesday, it could be a good time for investors to start tracking the company a bit more closely. The company revealed that it had put in place new management. A new Chief Operating Officer has been added in the form of Tom Stein. The company noted in its news release that Stein boasted more than two decades of experience in both executive and advisory roles in both small and large public and private companies.

He had worked at private CPG companies like Edrington, Diageo, and Bhang, as well as for advanced technology outfits like Plaier, YadaMedia, and MRM Technology. It was also noted that Stei was a specialist in not only business-to-business companies but also direct-to-consumer ones. Owing to his diverse experiences, Stein would be responsible for combining his expertise in CPG and technology to deploy machine learning, advanced data analytics, and artificial intelligence-powered insights for the creation of products that would connect strongly with modern-day consumers.

Caren Currier, the Chief Executive Officer of Tanke Biosciences Corp., noted that the particular approach to product development would allow the company to adjust to the latest market trends quickly and tailor its products to the preferences of customers. Other than that, the company announced that it had added a new director in the form of Hortencia Torres, Esq.

Torres was described as a highly experienced attorney and financial manager. Her experience stretched over a period of more than three decades. Currently, Torres is the managing partner at the conglomerate Global Groupa, which consists of legal associates, financial advisors, and global tax partners. It was further noted that throughout her career, she worked in the pharmaceutical and insurance industries for global companies.